A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma

European Journal of Cancer Care

Volumn 19, Issue 3, 2010, Pages 313-316

  Li, Y G ^a   Geng, X ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

ErbB2; HER 2; Meta analysis; Neu; Osteosarcoma; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; HUMAN; META ANALYSIS; METABOLISM; MORTALITY; OSTEOSARCOMA; PROGNOSIS; RISK; SURVIVAL;

ADOLESCENT; ADULT; BONE NEOPLASMS; HUMANS; OSTEOSARCOMA; PROGNOSIS; RECEPTOR, ERBB-2; RISK; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77953143213     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2008.00970.x     Document Type: Article

References (20)

1. Akatsuka T, Wada T, Kokai Y, Sawada N, Yamawaki S, Ishii S. Loss of erbb2 expression in pulmonary metastatic lesions in osteosarcoma. Oncology 2001, 60:361-366.
2. Akatsuka T, Wada T, Kokai Y, Kawaguchi S, Isu K, Yamashiro K, Yamashita T, Sawada N, Yamawaki S, Ishii S. ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer 2002, 94:1397-1404.
3. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 1986, 232:1644-1646.
4. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 1985, 230:1132-1139.
5. Gorlick R, Huvos AG, Heller G, Aledo A, Beardsley GP, Healey JH, Meyers PA. Expression of HER2/erbB-2 correlates with survival in osteosarcoma. Journal of Clinical Oncology 1999, 17:2781-2788.
6. Hynes NE, Stern DF. The biology of erbB-2/neu/HER2and its role in cancer. Biochimica et Biophysica Acta 1994, 1198:165-184.
7. Kilpatrick SE, Geisinger KR, King TS, Sciarrotta J, Ward WG, Gold SH, Bos GD. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma. Modern Pathology 2001, 14:1277-1283.
8. King CR, Kraus MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 1985, 229:974-976.
9. Maitra A, Wanzer D, Weinberg AG, Ashfaq R. Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. Cancer 2001, 92:677-683.
10. de Oliveira CR, Mendonçam BB, de Camargo OP, Pinto EM, Nascimento SA, Latorre Mdo R, Zerbini MC. Classical osteoblastoma, atypical osteoblastoma, and osteosarcoma: a comparative study based on clinical, histological, and biological parameters. Clinics 2007, 62:167-174.
11. Onda M, Matsuda S, Higaki S, Iijima T, Fukushima J, Yokokura A, Kojima T, Horiuchi H, Kurokawa T, Yamamoto T. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer 1996, 77:71-78.
12. Pakos EE, Ioannidis JP. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. Cancer 2003, 98:581-589.
13. Park YB, Kim HS, Oh JH, Lee SH. The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma. International Orthopaedics 2001, 24:307-310.
14. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
15. Trieb K, Kotz R. Proteins expressed in osteosarcoma and serum levels as prognostic factors. The International Journal of Biochemistry and Cell Biology 2001, 33:11-17.
16. Tsai CM, Yu D, Chang KT, Wu LH, Perng RP, Ibrahim NK, Hung MC. Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells. Journal of the National Cancer Institute 1995, 87:682-684.
17. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Research 1993, 53:891-898.
18. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC. C-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Research 1994, 54:3260-3266.
19. Yu D, Liu B, Tan M, Li J, Wang SS, Hung MC. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene 1996, 13:1359-1365.
20. Zhou H, Randall RL, Brothman AR, Maxwell T, Coffin CM, Goldsby RE. Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification. Journal of Pediatric Hematology Oncology 2003, 25:27-32.